Literature DB >> 3809887

Serum and synovial fluid histidine: a comparison in rheumatoid arthritis and osteoarthritis.

N G Sitton, J S Dixon, H A Bird, V Wright.   

Abstract

The serum and synovial fluid (SF) histidine, sulphydryl, and protein concentrations were compared in simultaneous samples from 84 patients with rheumatoid arthritis (RA) and a control group comprising 29 patients with osteoarthritis (OA). The SF levels of histidine were higher than the serum levels in the RA patients but significantly lower than corresponding results in patients with OA (P less than 0.001). The latter had levels of serum and SF histidine which were equivalent and within the normal range. Greater quantities of protein were found in the SF of the patients with RA compared with the OA group. The serum and SF sulphydryl concentrations expressed as mumol/g protein were low but in equilibrium in patients with RA. However the SF sulphydryl (mumol/g protein) was depressed relative to serum levels in patients with OA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3809887     DOI: 10.1007/bf00541315

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  SERUM SULFHYDRYL DETERMINATIONS AND SIGNIFICANCE IN CONNECTIVE TISSUE DISEASES.

Authors:  A LORBER; C M PEARSON; W L MEREDITH; L E GANTZ-MANDELL
Journal:  Ann Intern Med       Date:  1964-09       Impact factor: 25.391

2.  Functional significance of histamine and heparin in tissue mast cells.

Authors:  J F RILEY
Journal:  Ann N Y Acad Sci       Date:  1963-02-26       Impact factor: 5.691

Review 3.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations.

Authors:  A Lorber; R A Bovy; C C Chang
Journal:  Metabolism       Date:  1971-05       Impact factor: 8.694

5.  On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.

Authors:  M E Pickup; J S Dixon; H A Bird
Journal:  J Pharm Pharmacol       Date:  1980-04       Impact factor: 3.765

6.  Synovial permeability in rheumatoid arthritis.

Authors:  P A Simkin
Journal:  Arthritis Rheum       Date:  1979-07

7.  Plasma amino acids in rheumatoid arthritis.

Authors:  L E Trang; P Fürst; A C Odebäck; O Lövgren
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641

8.  The effect of drugs on serum histidine levels in rheumatoid arthritis.

Authors:  J S Dixon; N G Sitton; K E Surrall; M F Martin; M E Pickup; H A Bird
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity.

Authors:  D A Gerber
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

10.  Studies of histamine in the rheumatoid joint.

Authors:  A J Crisp
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

View more
  4 in total

Review 1.  A systems biology approach to synovial joint lubrication in health, injury, and disease.

Authors:  Alexander Y Hui; William J McCarty; Koichi Masuda; Gary S Firestein; Robert L Sah
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-08-08

2.  Diagnostic properties of metabolic perturbations in rheumatoid arthritis.

Authors:  Rasmus K Madsen; Torbjörn Lundstedt; Jon Gabrielsson; Carl-Johan Sennbro; Gerd-Marie Alenius; Thomas Moritz; Solbritt Rantapää-Dahlqvist; Johan Trygg
Journal:  Arthritis Res Ther       Date:  2011-02-08       Impact factor: 5.156

3.  The impact of inflammation on metabolomic profiles in patients with arthritis.

Authors:  Stephen P Young; Sabrina R Kapoor; Mark R Viant; Jonathan J Byrne; Andrew Filer; Christopher D Buckley; George D Kitas; Karim Raza
Journal:  Arthritis Rheum       Date:  2013-08

Review 4.  Can metabolic profiling provide a new description of osteoarthritis and enable a personalised medicine approach?

Authors:  M K J Jaggard; C L Boulangé; G Graça; U Vaghela; P Akhbari; R Bhattacharya; H R T Williams; J C Lindon; C M Gupte
Journal:  Clin Rheumatol       Date:  2020-06-01       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.